The Pyrazolone Originally Reported to Be a Formyl Peptide Receptor (FPR) 2/ALX-Selective Agonist Is Instead an FPR1 and FPR2/ALX Dual Agonist
A pyrazolone compound acting as a formyl peptide receptor (FPR) 2/ALX-selective agonist has been reported, but its pharmacological activities on human FPRs (hFPRs) and mouse FPRs (mFprs) have not been well demonstrated. In this study, we found that this compound, designated as compound A, induced co...
Saved in:
Main Authors: | Yoshitaka Sogawa (Author), Akiko Shimizugawa (Author), Takao Ohyama (Author), Hiroaki Maeda (Author), Kazuki Hirahara (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2009-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond
by: Sergio Sánchez-García, et al.
Published: (2023) -
Formyl Peptide Receptor 1 and 2 Dual Agonist Inhibits Human Neutrophil Chemotaxis by the Induction of Chemoattractant Receptor Cross-desensitization
by: Yoshitaka Sogawa, et al.
Published: (2011) -
Formyl peptide receptor type 2 (FPR2) deficiency in myeloid cells amplifies sepsis-induced cardiac dysfunction
by: Jianmin Chen, et al.
Published: (2023) -
Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism
by: Claudia Cristiano, et al.
Published: (2022) -
FPR1: A critical gatekeeper of the heart and brain
by: Ziyin Zhangsun, et al.
Published: (2024)